top of page

IQVIA Holdings Inc.

IQVIA Holdings Inc. is a global provider of advanced analytics, technology, and clinical research services.
It helps healthcare companies drive innovation and improve patient outcomes.

IQVIA Holdings Inc. stock investing summary image

Join Our Programs

Our clients trust us for our expert advice and in-depth market analysis. Discover our services to gain more knowledge on investing.

Growth Stock Analysis

Join our comprehensive growth stock analysis course designed for savvy investors. Learn how to evaluate stocks with a proven track record of delivering value and understand their potential for growth. Enhance your investment strategies with our expert-led insights.

Finance News Webinar

Join our Finance News Webinar for a clear breakdown of the most important financial stories shaping the markets today. We turn complex headlines into actionable insights, helping you understand what truly matters — and why.

Stock Market Webinar

Join our Stock Market Webinar to gain clear, actionable insights into current market trends. Learn how to analyse data, interpret signals, and make informed investment decisions with confidence. Designed for both beginners and experienced investors, this session delivers practical knowledge you can apply immediately.

Stock Analysis

Performance

​In 2024, IQVIA Holdings Inc. reported a 2.8% year-over-year increase in annual revenue, reaching $15.405 billion, with fourth-quarter revenue of $3.958 billion, up 2.3% from the previous year. The company achieved a GAAP net income of $1.373 billion for the year, marking a 1.1% rise, and adjusted net income of $2.042 billion, up 7.4%. Adjusted diluted earnings per share for the year were $11.13, a 9.1% increase. Adjusted EBITDA for 2024 was $3.684 billion, reflecting a 3.2% growth. The Technology & Analytics Solutions segment led with a 9.5% constant currency revenue growth in Q4, while the Research & Development Solutions segment experienced a slight decline. The company also reported record free cash flow of $721 million in Q4, contributing to a 49% year-over-year increase in free cash flow for the year.​

Quality of Earnings

The company demonstrates strong adherence to General Accounting Principles, with financial reports that conform to GAAP, are decision-useful, sustainable, and offer returns exceeding the cost of capital. There have been no recent changes to accounting policies, and all required financial reports are submitted on time. Revenue quality is also robust, marked by high predictability—with a substantial portion of clients returning year after year—strong profitability with gross margins exceeding 70%, diversified income sources with no client accounting for more than 15% of revenue, and clear growth in both revenue and net income. Additionally, there are no significant financial report warning signs: earnings contain minimal accrual components, do not narrowly beat benchmarks in a suspicious pattern, and revenue is not recognized prematurely. Expenses are not misrepresented, audit opinions are unqualified, goodwill is properly assessed, and the company does not rely on aggressive accounting tactics such as related-party transactions or off-balance-sheet debt. Operating ccash flows align with net income, earnings are recurring and persistent, and there is no history of restatements or enforcement actions, reinforcing the reliability and quality of the company’s financial reporting.

Financial Data Chart Company for Stock Analysis

Company Summary

​IQVIA Holdings Inc. is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, helping healthcare organizations accelerate innovation and improve patient outcomes.

Company Stock Analysis
bottom of page